Tackling COVID-19
As we stay apart, pharmaceutical companies are coming together to fight against COVID-19
LEARN MOREIntellectual Property
Europe’s framework of incentives and rewards for discovering and developing new treatments deliver access to today’s medicines and investment into tomorrow’s cures for patients who need them.
LEARN MORE
Help us make rare disease even rarer
Only 8 OMP medicines existed in 2000, before the EU Regulation came in to force, compared to 184 today.
LEARN MORE
Relationships and Code
EFPIA Code of Practice and relationships with patient organisations and healthcare professionals
LEARN MORE
Latest Updates
VIEW ALL-
Statements & press releases 08.04.21
All Together. No One Left Behind: Delays and the unavailability of medicines harm patients
Working together to address the root causes of delays and unavailability of medicines
Read Article -
Statements & press releases 30.03.21
EFPIA – Vaccines Europe response to global leaders urgent call for international pandemic treaty
The devastating human and economic cost of the COVID-19 pandemic has underlined the need for a global response.
Read Article -
Statements & press releases 26.03.21
EFPIA statement in response to the Council compromise agreement on the Commission Proposal for a Regulation...
Unfortunately, we regret that the Member States’ compromise risks creating a more inefficient system
Read Article -
External Events 15.04.21
Innovation for Health
On 15-16 April 2021, the 8th edition of Innovation for Health takes place as a hybrid edition.
View Event -
External Events 26.04.21
ATMP world tour
Speakers for this event come from all over the world and will present from their extensive knowledge in varied aspects of the ATMP pipeline
View Event -
External Events 26.04.21
Launch of the IP Principles for Advancing Cures and Therapies (IP PACT)
Launching the IP PACT: Our approach to Intellectual Property with patient and societal benefit at its core
View Event
Featured Articles
